RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.86
+0.01 (+1.22%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4,209.7% upside
Low Target
$30.65
Average Target
$37.15
High Target
$44.71
Current Price
$0.86
Current
$0.86
$0.86
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Scenario Analysis
Bear Case
$30.65
3,455.7%
Low target
Base Case
$37.15
+4,209.7%
Avg target
Bull Case
$44.71
+5,086.8%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$3.87
-77.7% from high
52-Week Low
$0.45
+93.7% from low
Target vs 52W High
$37.15
+859.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |